HYBRID EVENT: Join us in person in Rome, Italy or attend virtually from anywhere.

13th Edition of International Conference on

Neurology, Brain Health & Neurological Disorders

June 24-26, 2027 | Rome, Italy

Parkinson’s Disease

Parkinson’s Disease

Parkinson's disease is a progressive neurological disorder affecting nearly 1 million people in the United States. It is caused by a lack of dopamine-producing nerve cells in the brain. Symptoms of Parkinson's disease can include tremor, rigidity, slow movement, and difficulty with balance and walking. The severity of symptoms varies from person to person but can worsen with time. There is no known cure for Parkinson's disease, but medications and lifestyle changes can help manage symptoms and slow the progression of the disease. Levodopa is a central component of medication therapy for Parkinson's disease and is one of the most commonly prescribed medications for this condition. It works by helping the body produce dopamine, a neurotransmitter that is essential for the proper functioning of the central nervous system and movement. Levodopa is often combined with other medications, such as carbidopa, to improve efficacy and lessen side effects. These medications can improve daily functioning, such as allowing individuals to walk without assistance, and allow for faster and more coordinated movement. Recent advancements in treating Parkinson's disease include deep brain stimulation (DBS) and gene therapy. DBS involves surgically implanting an electronic device in the brain that sends electrical signals to areas believed to be associated with the symptoms of Parkinson's. These electrical signals can help reduce tremors and other motor symptoms. Gene therapy is another form of treatment that involves introducing genes into the body, specifically targeting areas of the brain that are affected by Parkinson's. While these treatments can be effective, they often come with risks and must be customized for each person's specific needs. Exercise is also an important component of managing Parkinson's disease. Regular physical activity can help improve mobility and daily functioning, as well as reduce fatigue. Exercise may also help to slow the long-term progression of the disease. Some people may also benefit from physical or occupational therapy to reduce symptoms and improve quality of life. Additionally, talk-therapy may be beneficial for those with Parkinson's to address depression, anxiety, and stress.

Committee Members
Speaker at  Neurology, Brain Health & Neurological Disorders 2027 - Yong Xiao Wang

Yong Xiao Wang

Albany Medical College, United States
Speaker at  Neurology, Brain Health & Neurological Disorders 2027 - Sid O Bryant

Sid O Bryant

Texas College of Osteopathic Medicine and University of North Texas Health Science Center Fort Worth, United States
Speaker at  Neurology, Brain Health & Neurological Disorders 2027 - W S El Masri

W S El Masri

Keele University, United Kingdom
Neurology 2027 Speakers
Speaker at  Neurology, Brain Health & Neurological Disorders 2027 - Luiz Moutinho

Luiz Moutinho

University of Suffolk, United Kingdom
Speaker at  Neurology, Brain Health & Neurological Disorders 2027 - Bernd Blobel

Bernd Blobel

University of Regensburg, Germany
Speaker at  Neurology, Brain Health & Neurological Disorders 2027 - Salvador Ventura

Salvador Ventura

Autonomous University of Barcelona, Spain
Speaker at  Neurology, Brain Health & Neurological Disorders 2027 - Zhenhuan Liu

Zhenhuan Liu

Guangzhou University of Chinese Medicine, China

Submit your abstract Today

Watsapp